|
Volumn 31, Issue 1, 2006, Pages 47-60
|
Aromatase in the context of breast and endometrial cancer. A review.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE;
AROMATASE INHIBITOR;
ESTROGEN;
ESTROGEN RECEPTOR;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TUMOR PROTEIN;
ADIPOSE TISSUE;
BIOSYNTHESIS;
BREAST;
BREAST TUMOR;
CARCINOMA;
CELL TRANSFORMATION;
CLINICAL TRIAL;
DRUG ANTAGONISM;
ENDOMETRIUM TUMOR;
ENZYMOLOGY;
FEMALE;
HUMAN;
HYPERPLASIA;
METABOLISM;
NEOPLASM;
OVARY;
PALLIATIVE THERAPY;
PATHOLOGY;
PHYSIOLOGY;
REVIEW;
STROMA CELL;
ADIPOSE TISSUE;
ANDROGENS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE;
AROMATASE INHIBITORS;
BREAST;
BREAST NEOPLASMS;
CARCINOMA;
CELL TRANSFORMATION, NEOPLASTIC;
CLINICAL TRIALS;
ENDOMETRIAL NEOPLASMS;
ESTROGEN RECEPTOR MODULATORS;
ESTROGENS;
FEMALE;
HUMANS;
HYPERPLASIA;
NEOPLASM PROTEINS;
NEOPLASMS, HORMONE-DEPENDENT;
OVARY;
PALLIATIVE CARE;
RECEPTORS, ESTROGEN;
STROMAL CELLS;
|
EID: 33646853725
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (23)
|
References (103)
|